BridgeBio Oncology Therapeutics (BBOT) Q4 2025 Earnings

Nov 12Confirmed
Q3 2025
Q4 2025
-49.62
-33.2
-16.79
-0.38

Details

Expected EPS
-0.381667
Actual EPS
-1.03
Surprise EPS
-0.65
Surprise Percent
-169.87%

Description

⁨BridgeBio Oncology Therapeutics⁩ (⁦BBOT⁩) has reported earnings of ⁦-1.03⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts